Risk Stratification in the Management of Chronic Lymphocytic Leukaemia (CLL); New Research in Chronic Lymphocytic Leukaemia; Transplantation Strategies for the Treatment of Chronic Lymphocytic Leukaemia; What is the Clinical and Biological Significance of the BCL-2 Family n Apoptosis Regulation in B-Cell Chronic Lymphocytic Leukaemia (CLL)?; Mode of Action of Rituximab in Chronic Lymphocytic Leukaemia; Activation of Tis11b, an Inducer of MRNA Instability and Induction of Apoptosis; Genetic Factors Impacting the Biology of B Cell Chronic Lymphocytic Leukaemia (B-CLL); The "In Vitro Apoptosis" Profile in CLL Correlates with some Prognostic Markers, Treatment History and In Vivo Response to Treatment; CD38 Expression in B-Cell Chronic Lymphocytic Leukaemia: What have we learned?; Novel and Uncommon Chromosome Aberrations in Chronic-Lymphocytic Leukaemia: Cytogenetic, FISH and Clinical Evaluation; Index.